IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q1 2025 Holdings

Filed 2025-05-15 | 17 holdings | $198.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Genedx Holdings Corp(WGS)COM CL A81663L200$85.9M969,95443.3%
Springworks Therapeutics IncCOM85205L107$23.4M531,35111.8%
Spdr SER TRCallCALL78464A900$22.7M280,00011.5%
Biohaven LTD(BHVN)COMG1110E107$16.0M665,9458.1%
Ardelyx Inc(ARDX)COM039697107$11.8M2,404,4386.0%
Viking Therapeutics IncCallCALL92686J906$8.1M336,7004.1%
Ardelyx IncCallCALL039697907$5.6M1,133,5002.8%
Teladoc Health Inc(TDOC)COM87918A105$4.5M565,9002.3%
Quidelortho Corp(QDEL)COM219798105$4.1M118,2912.1%
Biohaven LTD(BHVN)CallCALLG1110E907$3.9M161,9002.0%
Peloton Interactive IncCallCALL70614W900$3.2M500,0001.6%
Forian Inc(FORA)COM34630N106$2.7M1,366,1071.4%
Palantir Technologies Inc(PLTR)CL A69608A108$2.5M29,5001.3%
Cava Group Inc(CAVA)COM148929102$1.6M18,6000.8%
Teladoc Health IncCallCALL87918A905$1.1M144,3000.6%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$634.8K120,0000.3%
Biogen Inc(BIIB)COM09062X103$330.1K2,4120.2%